These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28100678)

  • 1. Modulation of Naive CD8 T Cell Response Features by Ligand Density, Affinity, and Continued Signaling via Internalized TCRs.
    Balyan R; Gund R; Ebenezer C; Khalsa JK; Verghese DA; Krishnamurthy T; George A; Bal V; Rath S; Chaudhry A
    J Immunol; 2017 Mar; 198(5):1823-1837. PubMed ID: 28100678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
    Curtsinger JM; Lins DC; Mescher MF
    J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of anti-tumor immunity by tolerogenic dendritic cells.
    Chen L; Hasni MS; Jondal M; Yakimchuk K
    Autoimmunity; 2017 Sep; 50(6):370-376. PubMed ID: 28675711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gads regulates the expansion phase of CD8+ T cell-mediated immunity.
    Zhang EY; Parker BL; Yankee TM
    J Immunol; 2011 Apr; 186(8):4579-89. PubMed ID: 21411729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.
    Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF
    J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
    Shier P; Ngo K; Fung-Leung WP
    J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous TCR and CD244 signals induce dynamic downmodulation of CD244 on human antiviral T cells.
    Pacheco Y; McLean AP; Rohrbach J; Porichis F; Kaufmann DE; Kavanagh DG
    J Immunol; 2013 Sep; 191(5):2072-81. PubMed ID: 23913963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dicer controls CD8+ T-cell activation, migration, and survival.
    Zhang N; Bevan MJ
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21629-34. PubMed ID: 21098294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 down-regulates the expression of TCR and TCR-associated surface molecules on CD8(+) T cells.
    Kambayashi T; Assarsson E; Chambers BJ; Ljunggren HG
    Eur J Immunol; 2001 Nov; 31(11):3248-54. PubMed ID: 11745341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes.
    Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S
    Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR ligand avidity determines the mode of B-Raf/Raf-1/ERK activation leading to the activation of human CD4+ T cell clone.
    Tsukamoto H; Irie A; Chen YZ; Takeshita K; Kim JR; Nishimura Y
    Eur J Immunol; 2006 Jul; 36(7):1926-37. PubMed ID: 16791876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pMHC affinity controls duration of CD8+ T cell-DC interactions and imprints timing of effector differentiation versus expansion.
    Ozga AJ; Moalli F; Abe J; Swoger J; Sharpe J; Zehn D; Kreutzfeldt M; Merkler D; Ripoll J; Stein JV
    J Exp Med; 2016 Nov; 213(12):2811-2829. PubMed ID: 27799622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Methadone Use Alters the CD8
    Mazahery C; Benson BL; Cruz-Lebrón A; Levine AD
    J Immunol; 2020 Mar; 204(5):1188-1200. PubMed ID: 31969385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactive CD8 T cells rescued from apoptosis during co-stimulation blockade by Toll-like receptor stimulation remain susceptible to Fas-induced cell death.
    Priyadharshini B; Thornley TB; Daniels KA; Cuthbert A; Welsh RM; Greiner DL; Brehm MA
    Immunology; 2013 Apr; 138(4):322-32. PubMed ID: 23190301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.
    Fields PE; Finch RJ; Gray GS; Zollner R; Thomas JL; Sturmhoefel K; Lee K; Wolf S; Gajewski TF; Fitch FW
    J Immunol; 1998 Nov; 161(10):5268-75. PubMed ID: 9820499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.
    Au-Yeung BB; Smith GA; Mueller JL; Heyn CS; Jaszczak RG; Weiss A; Zikherman J
    J Immunol; 2017 Mar; 198(6):2445-2456. PubMed ID: 28159902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific activation thresholds of CD8+ T cells are independent of IFN-I-mediated partial lymphocyte activation.
    Wijesundara DK; Kumar S; Alsharifi M; Müllbacher A; Regner M
    Int Immunol; 2010 Sep; 22(9):757-67. PubMed ID: 20682547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12-mediated STAT4 signaling and TCR signal strength cooperate in the induction of CD40L in human and mouse CD8+ T cells.
    Stark R; Hartung A; Zehn D; Frentsch M; Thiel A
    Eur J Immunol; 2013 Jun; 43(6):1511-7. PubMed ID: 23765345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.